Sensus Healthcare Q1 revenue falls 59% on absence of largest customer

Sensus Healthcare

07/05/2026 21:31

Overview

US medical device maker's Q1 revenue fell, missing analyst expectations

Revenue decline driven by absence of sales to largest customer and fewer units shipped

Company saw increased customer activity and diversification after new CPT codes became effective

Outlook

Company expects new CPT codes to drive increased customer activity and sales pipeline quality

Sensus Healthcare aims to expand recurring revenue and advance toward profitability in 2026

Company reports increased interest from independent practices and hospitals following reimbursement changes

Result Drivers

CUSTOMER DIVERSIFICATION - Excluding sales to the largest customer, revenue increased year-over-year, reflecting progress in diversifying the customer base

REIMBURSEMENT CLARITY - Implementation of dedicated CPT codes for SRT led to increased inquiries, stronger pipeline activity, and greater customer engagement

RECURRING REVENUE INITIATIVES - Expansion of Fair Deal Agreement program and launch of financial services supported customer acquisition and recurring revenue growth

Company press release: ID:nBw8TJLP7a

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Miss
$3.39 mln
$5.32 mln (4 Analysts)
Q1 Net Income
-$2.63 mln
Q1 Adjusted EBITDA
Miss
-$4.19 mln
-$2.42 mln (2 Analysts)
Q1 Basic EPS
-$0.16
Q1 Operating Expenses
$5.35 mln
Q1 Pretax Profit
-$4.23 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 4 "strong buy" or "buy", no "hold" and no "sell" or "strong sell"

The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"

Wall Street's median 12-month price target for Sensus Healthcare Inc is $6.75, about 65% above its May 6 closing price of $4.09

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)